Innehållsförteckning
What is HSV-2 (HSV-1)?
HSV-2 is a sexually transmitted infection that causes genital herpes. Both HSV-1 and HSV-2 infections are lifelong. An estimated 3.7 billion people under age 50 (67%) have HSV-1 infection globally.
What are the long-term effects of HSV1 and HSV2?
In people with weak or compromised immune systems — such as people with HIV — both HSV-1 and HSV-2 can cause lasting damage to the eyes and brain. HSV-1 and HSV-2 can both potentially cause neonatal herpes. This is a potentially fatal virus caused by vertical transmission of herpes from mother to child.
What is the mode of transmission of HSV 1?
Transmission. HSV-1 is mainly transmitted by oral-to-oral contact to cause oral herpes infection, via contact with the HSV-1 virus in sores, saliva, and surfaces in or around the mouth. However, HSV-1 can also be transmitted to the genital area through oral-genital contact to cause genital herpes.
What is the best treatment for HSV 1 and HSV 2?
HSV-1 and HSV-2 are both easy and inexpensive viruses to treat. The most widely used drugs for both forms of the herpes virus are antiviral medications, such as valacyclovir (Valtrex) and acyclovir (Zovirax).
What are the possible complications of herpes simplex virus (HSV-2)?
In advanced HIV disease, HSV-2 can lead to more serious, but rare, complications such as meningoencephalitis, esophagitis, hepatitis, pneumonitis, retinal necrosis, or disseminated infection. Neonatal herpes can occur when an infant is exposed to HSV (HSV-2 or HSV-1) in the genital tract during delivery.
What are the symptoms of HSV-2?
This may include a fever, chronic and severe fatigue, nausea, and dizziness. The issue with an HSV 2 infection is that the body is always shedding the active virus. People can transmit HSV 2 even if they aren’t experiencing active symptoms. The herpes virus can also make people 2x more susceptible to other STD infections, particularly HIV.
What is the global prevalence of HSV2?
HSV-2 is a sexually transmitted infection that causes genital herpes. Both HSV-1 and HSV-2 infections are lifelong. An estimated 3.7 billion people under age 50 (67%) have HSV-1 infection globally. An estimated 491 million people aged 15-49 (13%) worldwide have HSV-2 infection.